Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Line Metastatic Pancreatic Cancer	08-12-20
SUN BIOP : BioPharma to Change Name to Panbela Therapeutics	01-12-20
SUN BIOP : Earnings Flash (SNBP) SUN BIOPHARMA Posts Q3 EPS $-0.21	12-11-20
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results	12-11-20
Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference	10-11-20

Bedrijfsprofiel

Sector